Zobrazeno 1 - 10 of 11 pro vyhledávání: '"Katie Griffin"'
1
Cystic fibrosis–related diabetes onset can be predicted using biomarkers measured at birth
Autor: Emmanuelle Brochiero, Pearce G. Wilcox, Lara Bilodeau, Mays Merjaneh, Nancy Morrison, Lisa J. Strug, Angela Hillaby, Julie Avolio, Katherine Keenan, Lynda Lazosky, Jennifer Itterman, Michael D. Parkins, Émilie Maille, Naim Panjwani, Mark A. Chilvers, Lei Sun, Jennifer Pike, Richard van Wylick, Yu Chung Lin, Raquel Consunji-Araneta, Caroline Burgess, Lorna Kosteniuk, Lori Fairservice, Christine Donnelly, Natalie Henderson, Damien Adam, Scott M. Blackman, Dimas Mateos-Corral, Bradley S. Quon, Mary Jackson, Janna Brusky, Felix Ratjen, Elizabeth Tullis, Garry R. Cutting, Clare Smith, Melinda Solomon, Harriet Corvol, Valerie Levesque, Daniel Hughes, Fan Lin, Nathalie Vadeboncoeur, Candice Bjornson, Yves Berthiaume, Guillaume Côté-Maurais, Anne L. Stephenson, Winnie Leung, Shaikh Iqbal, Jiafen Gong, Johanna M. Rommens, Mary Jane Smith, Paula Barrett, Joe Reisman, Terry Viczko, Katie Griffin, Danny Veniott, Vanessa McMahon, Stéphanie Bégin, April Price, Emma Karlsen, Andrea Dale
Publikováno v: Genetics in Medicine
Purpose Cystic fibrosis (CF), caused by pathogenic variants in the CF transmembrane conductance regulator (CFTR), affects multiple organs including the exocrine pancreas, which is a causal contributor to cystic fibrosis–related diabetes (CFRD). Unt
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1ef7943d8c7bf7fcea5b30444d5d821
https://doi.org/10.1038/s41436-020-01073-x
Zobrazit plný text záznamu
2
Correction to: Cystic fibrosis–related diabetes onset can be predicted using biomarkers measured at birth
Autor: Julie Avolio, Lorna Kosteniuk, Mays Merjaneh, Emmanuelle Brochiero, Pearce G. Wilcox, Yu-Chung Lin, Nancy Morrison, Katherine Keenan, Mark A. Chilvers, April Price, Melinda Solomon, Damien Adam, Dimas Mateos-Corral, Felix Ratjen, Jennifer Pike, Bradley S. Quon, Scott M. Blackman, Vanessa McMahon, Anne L. Stephenson, Joe Reisman, Terry Viczko, Mary Jackson, Natalie Henderson, Naim Panjwani, Nathalie Vadeboncoeur, Émilie Maille, Caroline Burgess, Katie Griffin, Harriet Corvol, Danny Veniott, Lori Fairservice, Shaikh Iqbal, Angela Hillaby, Raquel Consunji-Araneta, Christine Donnelly, Guillaume Côté-Maurais, Emma Karlsen, Clare Smith, Elizabeth Tullis, Andrea Dale, Winnie Leung, Paula Barrett, Lei Sun, Mary Jane Smith, Daniel Hughes, Stéphanie Bégin, Janna Brusky, Candice Bjornson, Lynda Lazosky, Richard van Wylick, Michael D. Parkins, Yves Berthiaume, Lara Bilodeau, Johanna M. Rommens, Lisa J. Strug, Jennifer Itterman, Valerie Levesque, Fan Lin, Jiafen Gong, Garry R. Cutting
Publikováno v: Genetics in Medicine
Cystic fibrosis (CF), caused by pathogenic variants in the CF transmembrane conductance regulator (CFTR), affects multiple organs including the exocrine pancreas, which is a causal contributor to cystic fibrosis-related diabetes (CFRD). Untreated CFR
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a58bc4c6d23bddeb54bbae662e77180d
https://doi.org/10.1038/s41436-021-01281-z
Zobrazit plný text záznamu
3
Total and Partial Urogenital Mobilization: Focus on Urinary Continence
Autor: Dominic Frimberger, Amy B. Wisniewski, Brandon Trojan, Bradley P. Kropp, William G. Reiner, Katie Griffin, Blake W. Palmer
Publikováno v: Journal of Urology. 187:1422-1426
Total and partial urogenital mobilization procedures are the most common contemporary vaginoplasty surgeries for patients with congenital adrenal hyperplasia, urogenital sinus and cloacal anomalies. There is controversy regarding the urinary continen
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd323051b72d3e4db3eca1175b050d4f
https://doi.org/10.1016/j.juro.2011.12.012
Zobrazit plný text záznamu
6
A phase II study of palbociclib (P) for previously treated cell cycle gene alteration positive patients (pts) with stage IV squamous cell lung cancer (SCC): Lung-MAP sub-study SWOG S1400C
Autor: David R. Gandara, Roy S. Herbst, Kathy S. Albain, Eric C. McGary, Mary W. Redman, Katie Griffin, Norman Rafique, Martin J. Edelman, Vassiliki A. Papadimitrakopoulou, Saiama N. Waqar, Karen Kelly, Jieling Miao, Daniel P. Petro
Publikováno v: Journal of Clinical Oncology. 35:9056-9056
9056 Background: S1400 is a master platform trial designed to assess targeted therapies in SCC. Study C evaluated the response rate (RR) to P, a CDK 4/6 inhibitor, in pts with cell cycle gene abnormalities. Methods: Pts with SCC, PS 0-2, normal organ
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1b26e3b9722ed597104778c73b6ac8a2
https://doi.org/10.1200/jco.2017.35.15_suppl.9056
Zobrazit plný text záznamu
7
Phase II study of the FGFR inhibitor AZD4547 in previously treated patients with FGF pathway-activated stage IV squamous cell lung cancer (SqNSCLC): LUNG-MAP sub-study SWOG S1400D
Autor: Vassiliki A. Papadimitrakopoulou, Karen Kelly, Roy S. Herbst, Jeffrey D. Bradley, David R. Gandara, Hossein Borghaei, Charu Aggarwal, Philip C. Hoffman, Katie Griffin, Philip C. Mack, Primo N. Lara, Mary W. Redman, Jieling Miao
Publikováno v: Journal of Clinical Oncology. 35:9055-9055
9055 Background: LungMAP is a National Clinical Trials Network umbrella trial for previously-treated SqNSCLC. S1400D is a phase II biomarker-driven therapeutic sub-study evaluating the FGFR inhibitor AZD4547 in patients (pts) with FGFR positive chemo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9d0f5cb119c3e9f9661939207ea03b36
https://doi.org/10.1200/jco.2017.35.15_suppl.9055
Zobrazit plný text záznamu
8
A phase II study of GDC-0032 (taselisib) for previously treated PI3K positive patients with stage IV squamous cell lung cancer (SqNSCLC): LUNG-MAP sub-study SWOG S1400B
Autor: Roy S. Herbst, Jeffrey Crawford, Katie Griffin, Corey J. Langer, Karen Kelly, Mary W. Redman, David R. Gandara, Vassiliki A. Papadimitrakopoulou, Jeffrey D. Bradley, Charu Aggarwal, James L. Wade, Jieling Miao
Publikováno v: Journal of Clinical Oncology. 35:9054-9054
9054 Background: Lung-MAP (S1400) is a National Clinical Trials Network “umbrella” trial for previously-treated SqNSCLC. Sub-study S1400B included patients (pts) with tumors harboring PI3K mutations.Taselisib (GDC-0032), a potent, small molecule
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f6a7303705a45b58f66f97f1192eb37f
https://doi.org/10.1200/jco.2017.35.15_suppl.9054
Zobrazit plný text záznamu
9
Medical therapy for acquired urinary incontinence in dogs
Autor: Katie, Hill, Dinah, Jordan, Jody, Ray, Andrew A, Mays, Katie, Griffin
Publikováno v: International journal of pharmaceutical compounding. 16(5)
The objective of this case report was to review acquired canine urethral incontinence in a case of a 2-year-old beagle that presented for inappropriate urination. Commercially available medications, as well as compounded medical therapeutic options,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7a655985e0500f2ddf182bcac6e3a4a7
https://pubmed.ncbi.nlm.nih.gov/23072196
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje